Abstract
Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: aproposed approach to SARS-CoV-2 treatment.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have